Go to Top


  • Publications & Press

  • TV & radio

Orthopedic Cement Injection Technology Acquired by Vexim

Written by Heather Linder | February 28, 2013

Vexim has acquired a system to mix and inject orthopedic cement for vertebroplasty procedures. The technology will be incorporated into the company’s SpineJack implant, a minimally invasive device for treatment of vertebral compression factures. The orthopedic cement technology will allow Vexim to expand its presence in vertebroplasty. Injecting cement into the vertebra will also allow surgery to be performed on cases where stabilizing the fracture and eliminating pain are priorities, according to the report. The system is scheduled to launch simultaneously in Europe and the U.S. in 2014.

Mergers and Acquisitions 2013

By Madeleine Armstrong, Editor, Business In order to keep track of the busy medtech mergers

In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its ‘live’ M&A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2012 so far.

+ d’info

Vexim acquires new cement injector for vertebroplasty

By AMANDA PEDERSEN – Medical Device Daily Senior Staff Writer

Vexim (Toulouse, France), a company developing technology for vertebral fractures, said it has acquired a new orthopedic cement injection system for its development in vertebroplasty. The company had already made its mark in the space with its SpineJack implant, a device designed to treat vertebral compression fractions in a minimally invasive way, enabling the anatomic restoration of fractured vertebra and the reestablishment of the spinal column’s balance.

+ d’info

Vexim acquires new technology

Elizabeth Hofheinz, M.P.H., M.Ed. • Wed, March 6th, 2013

Vexim, a French company focused on the minimally invasive treatment of vertebral fractures, has announced the acquisition of an innovative technological system in the injection of orthopedic cement for its development in vertebroplasty. The system was developed by Altavance, a Swiss company.

+ d’info

Vexim’ s 2012 growth confirms SpineJack adoption in Europe

Medical Industry Week | 18/01/2013

Vexim , a Toulouse , France-based company focused on developing minimally–invasive products to treat traumatic spinal pathologies , has reported its sales for the second half and full-year 2012 financial results.

+ d’info

European Markets for Spinal Implants and VCF

Scottrade | 06/02/2013

Reportlinker.com announces that a new market research report is available in its catalogue: The European spinal implant market is expected to exceed EUR 1 billion by 2018. Growth in the interbody fusion device segment will continue to be the largest contributor to the rising spinal implant market.

+ d’info


February 5, 2013

BFM Business

January 13, 2013

BFM Business


You need to install or upgrade Flash Player to view this content, install or upgrade by clicking here.